FDA Inspection
Boehringer Ingelheim Pharma GmbH & Co. KGFDA Inspection 1053519 - Boehringer Ingelheim Pharma GmbH & Co. KG - May 04, 2018
Discuss this record with AI
Record Details
This FDA Inspection record concerns Boehringer Ingelheim Pharma GmbH & Co. KG, with an inspection on May 4, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
Open in Dashboard
ID · 256e5980-df7b-4049-9703-ac50c6fbc5de